FIELD: medicine, oncogynecology. SUBSTANCE: method involves the preliminary sensitivity assay of patients to cyclic adenosine-3',5'-monophosphate sodium salt. This preparation is administrated to the sensitive patients at concentration 3 x 10-5 M by intranasal or sublingual routes, 3 times per 24 h, every other day, beginning from 6 drops at the first day and increasing dose by 2 drops for the following days up to the total amount 14 drops. Then the indicated dose is administrated up to the treatment course end that continues for 30 days. EFFECT: decreased complications, enhanced effectiveness of treatment.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF MAMMA CANCER TREATMENT | 1995 |
|
RU2071771C1 |
| METHOD OF TREATMENT OF ONCOLOGICAL PATIENTS | 1998 |
|
RU2137495C1 |
| ANTITUMOR AGENT (VARIANTS) | 1992 |
|
RU2061480C1 |
| METHOD OF COMBINATION THERAPY APPLIED FOR LOCALLY ADVANCED CERVICAL CARCINOMA TYPES | 2006 |
|
RU2325199C2 |
| METHOD FOR TREATING THE CASES OF DISSEMINATED OVARIAN CARCINOMA | 2005 |
|
RU2283107C1 |
| METHOD OF TREATING OVARIAN CANCER, VERSIONS OF ITS METASTASIS AND RECURRENCE | 2015 |
|
RU2582939C1 |
| METHOD OF TREATING ADVANCED OVARIAN CARCINOMA WITH DISTANT METASTASES | 2008 |
|
RU2395314C2 |
| METHOD FOR TREATMENT OF INOPERABLE ASCTIC FORMS OF OVARIAN CANCER | 2016 |
|
RU2624509C1 |
| METHOD FOR TREATING UTERINE CHORIOCARCINOMA CASES | 2006 |
|
RU2318502C2 |
| METHOD OF TREATMENT OF PATIENTS WITH OVARIAN CANCER | 2007 |
|
RU2352341C1 |
